Benicar Lawsuit Assistance February 20, 2024 …Studies Regarding Benicar FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil: The U.S. Food and Drug Administration (FDA) is warning that… Read More
Boehringer-Ingelheim Recalls Pradaxa…But Don’t Get Excited January 4, 2015 …Risk For Serious Bleeding Events With The Anticoagulant Pradaxa,” 02 November 2012. Available at http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm . MacDonald, Gareth. “Boehringer Withdraws Pradaxa Lot After Packaging Line Problems.” InPharma Technologist, 12 November 2012. Available at http://www.in-pharmatechnologist.com/Processing/Boehringer-withdraws-Pradaxa-lot-after-packaging-line-problems. N/A…. Read More
GlaxoSmithKline Pays Billions in Criminal and Civil Penalties for False Claims June 28, 2024 …cancer, it might be a good idea to market it for that purpose. The result: Zofran birth defects, including cleft palate and congenital heart problems. Back to the Zofran lawsuit:… Read More
Levin Law
Levin Law